(A) Landmark analysis of survival of patients achieving a reduction in GDF-15 by ≥25% at 6 months. (B) Risk of dialysis for patients presenting with GDF-15 >4000 pg/mL. See Figures 1C and 2A in the article by Kastritis et al that begins on page 1568.

(A) Landmark analysis of survival of patients achieving a reduction in GDF-15 by ≥25% at 6 months. (B) Risk of dialysis for patients presenting with GDF-15 >4000 pg/mL. See Figures 1C and 2A in the article by Kastritis et al that begins on page 1568.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal